Paratek Pharmaceuticals
MA - BostonPharmaceutical
Focus: Paratek Pharmaceuticals is a specialty pharma company headquartered in Boston focused on small molecule therapeutics in neurology and infectious disease. The company is heavily dependent on its commercial portfolio, with XHANCE generating 100% of reported revenue.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
24+3 this month
Stable — net +3 jobs in 30d
7 added, 4 removed. Backfill posture.
Should You Work at Paratek Pharmaceuticals?
AI assessmentParatek offers near-term stability for commercial and early-development roles, but career longevity depends entirely on pipeline success post-2036 patent cliffs.
Why Work Here
- Two marketed products at peak lifecycle stage (XHANCE LOE 2036, NUZYRA LOE 2037) provide revenue stability through at least mid-2030s
- Active pipeline with 16 clinical programs including three Phase 3 trials in high-value indications (bacterial pneumonia, soft tissue infections, diabetic complications)
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
1 imminent
FLUTICASONE PROPIONATE
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$18M Part DStable
Peak9.8yr
Sole revenue driver for the company; represents 100% of reported revenue and accounts for $18M in Part D spending.
Help build intelligence for Paratek Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.